Existing medical implants are, in the main, merely tolerated by the surrounding tissue. The Cambridge Centre for Medical Materials (CCMM) at the University of Cambridge Department of Materials Science & Metallurgy researches the next generation of medical materials which interact therapeutically with the body, having bioactive structures which encourage the tissue’s natural function, as well as, for example, providing tailored mechanical support, or releasing drugs at a controlled rate. The group has a strong track record in the fields of skeletal implants, medical prostheses and devices, drug delivery systems, tissue engineering, bioceramics and bioactive coatings and resorbable and stable polymers for implantation.
Existing medical implants are, in the main, merely tolerated by the surrounding tissue. The Cambridge Centre for Medical Materials (CCMM) at the University of Cambridge Department of Materials Science & Metallurgy researches the next generation of medical materials which interact therapeutically with the body, having bioactive structures which encourage the tissue’s natural function, as well as, for example, providing tailored mechanical support, or releasing drugs at a controlled rate. The group has a strong track record in the fields of skeletal implants, medical prostheses and devices, drug delivery systems, tissue engineering, bioceramics and bioactive coatings and resorbable and stable polymers for implantation.
The CCMM has signed a three-year development agreement with Inion for work on innovative medical implants.
The Cambridge Centre for Medical Materials (CCMM) is co-directed by Dr Ruth Cameron and Dr Serena Best. It was founded in 2000 by Professor William Bonfield to pioneer research into novel materials for medical application. It has strong links with the prestigious Orthopaedic Research Unit, headed by Professor Neil Rushton, Professor of Orthopaedics at Addenbrooke’s Hospital.
Inion designs and manufactures biodegradable plates, screws, pins and membranes that are used to enhance the healing of skeletal injuries (bone and soft tissue), such as those caused by trauma or by reconstructive surgery. The University departments will collaborate with Inion on developing a new medical materials platform combining the proprietary Inion Optima[TM] biodegradable polymers with nano-phase bioactive ceramics under development at the University.
This work is licensed under a Creative Commons Licence. If you use this content on your site please link back to this page.